Analysts predict that Kymera Therapeutics, Inc. (NASDAQ:KYMR) will post $22.32 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Kymera Therapeutics’ earnings. The lowest sales estimate is $19.64 million and the highest is $25.00 million. The business is scheduled to issue its next earnings report on Thursday, August 5th. […]
